{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:38:35Z","timestamp":1792604315794,"version":"4.5.0"},"publisher-location":"Cham","reference-count":36,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032294364","type":"print"},{"value":"9783032294371","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-29437-1_15","type":"book-chapter","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:51:46Z","timestamp":1792601506000},"page":"255-262","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mapping the Proteomes of Bacteriophages E215 and LUZ19 Using Liquid Chromatography Tandem Mass Spectrometry"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3597-3884","authenticated-orcid":false,"given":"Connor E.","family":"Gould","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alhaji Simon","family":"Ekere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1069-1720","authenticated-orcid":false,"given":"Thomas D.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob T.","family":"Sanborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5845-2235","authenticated-orcid":false,"given":"Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2069-8915","authenticated-orcid":false,"given":"Dwayne R.","family":"Roach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0212-2787","authenticated-orcid":false,"given":"Nicholas M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2556-8511","authenticated-orcid":false,"given":"Troy D.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2027,1,23]]},"reference":[{"key":"15_CR1","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s15010-021-01709-3","volume":"50","author":"JA Al-Tawfiq","year":"2022","unstructured":"Al-Tawfiq JA, Momattin H, Al-Ali AY, Eljaaly K et al. (2022) Antibiotics in the pipeline: a literature review (2017-2020). Infection 50:553\u2013564","journal-title":"Infection"},{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1093\/cid\/cit152","volume":"56","author":"HW Boucher","year":"2013","unstructured":"Boucher HW, Talbot GH, Benjamin Jr.DK, Bradley J et al. (2013) 10 x \u201820 Progress\u2014development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America. Clin Infect Dis 56:1685\u20131694","journal-title":"Clin Infect Dis"},{"key":"15_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41429-020-0291-8","volume":"73","author":"MS Butler","year":"2020","unstructured":"Butler MS, Paterson DL (2020) Antibiotics in the clinical pipeline in October 2019. J Antibiot (Tokyo) 73:329\u2013364","journal-title":"J Antibiot (Tokyo)"},{"key":"15_CR4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S et al. (2018) Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 18:318\u2013327","journal-title":"Lancet Infect Dis"},{"key":"15_CR5","doi-asserted-by":"crossref","unstructured":"Jin Y, Li W, Zhang H, Ba X et al (2023) The post-antibiotic era: a new dawn for bacteriophages. Biology (Basel) 12:681s","DOI":"10.3390\/biology12050681"},{"key":"15_CR6","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s40121-022-00591-2","volume":"11","author":"AJ Kunz Coyne","year":"2022","unstructured":"Kunz Coyne AJ, El Ghali A, Holger D, Rebold N, Rybak MJ (2022) Therapeutic strategies for emerging multidrug-resistant Pseudomonas aeruginosa. Infect Dis Ther 11:661\u2013682","journal-title":"Infect Dis Ther"},{"key":"15_CR7","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/bph.14106","volume":"175","author":"A Forde","year":"2018","unstructured":"Forde A, Hill C (2018) Phages of life\u2014the path to pharma. Br J Pharmacol 175:412\u2013418","journal-title":"Br J Pharmacol"},{"key":"15_CR8","doi-asserted-by":"publisher","first-page":"veae007","DOI":"10.1093\/ve\/veae007","volume":"10","author":"J Romeyer Dherbey","year":"2024","unstructured":"Romeyer Dherbey J, Bertels F (2024) The untapped potential of phage model systems as therapeutic agents. Virus Evol 10:veae007","journal-title":"Virus Evol"},{"key":"15_CR9","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1038\/s41596-020-0346-0","volume":"15","author":"T Luong","year":"2020","unstructured":"Luong T, Salabarria A-C, Edwards RA, Roach DR (2020) Standardized bacteriophage purification for personalized phage therapy. Nat Protoc 15:2867\u20132890","journal-title":"Nat Protoc"},{"key":"15_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev-med-080219-122208","volume":"73","author":"GF Hatfull","year":"2022","unstructured":"Hatfull GF, Dedrick RM, Schooley RT (2022) Phage therapy for antibiotic-resistant bacterial infections. Annu Rev Med 73:197\u2013211","journal-title":"Annu Rev Med"},{"key":"15_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4161\/bact.1.1.14942","volume":"1","author":"MR Clokie","year":"2011","unstructured":"Clokie MR, Millard AD, Letarov AV, Heaphy S (2011) Phages in nature. Bacteriophage 1:31\u201345","journal-title":"Bacteriophage"},{"key":"15_CR12","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/v10070351","volume":"10","author":"F Oechslin","year":"2018","unstructured":"Oechslin F (2018) Resistance development to bacteriophages occurring during bacteriophage therapy. Viruses 10:351","journal-title":"Viruses"},{"key":"15_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4161\/bact.1.2.14590","volume":"1","author":"C Loc-Carrillo","year":"2011","unstructured":"Loc-Carrillo C, Abedon ST (2011) Pros and cons of phage therapy. Bacteriophage 1:111\u2013114","journal-title":"Bacteriophage"},{"key":"15_CR14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4292\/wjgpt.v8.i3.162","volume":"8","author":"DM Lin","year":"2017","unstructured":"Lin DM, Koskella B, Lin HC (2017) Phage therapy: an alternative to antibiotics in the age of multi-drug resistance. World J Gastrointest Pharmacol Ther 8:162\u2013173","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"15_CR15","doi-asserted-by":"crossref","unstructured":"Smith NM, Nguyen TD, Chin WH, Sanborn JT et al (2023) A mechanism-based pathway toward administering highly active N-phage cocktails. Front Microbiol 14:1292618","DOI":"10.3389\/fmicb.2023.1292618"},{"key":"15_CR16","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1038\/s41598-018-37636-x","volume":"9","author":"M Cafora","year":"2019","unstructured":"Cafora M, Deflorian G, Forti F, Ferrari L et al. (2019) Phage therapy against Pseudomonas aeruginosa infections in a cystic fibrosis zebrafish model. Sci Rep 9:1527\u20131527","journal-title":"Sci Rep"},{"key":"15_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1056\/NEJMra1300109","volume":"372","author":"DA Stoltz","year":"2015","unstructured":"Stoltz DA, Meyerholz DK, Welsh MJ (2015) Origins of cystic fibrosis lung disease. N Engl J Med 372:351\u2013362","journal-title":"N Engl J Med"},{"key":"15_CR18","doi-asserted-by":"publisher","first-page":"100030","DOI":"10.1016\/j.microb.2023.100030","volume":"2","author":"A Nawaz","year":"2024","unstructured":"Nawaz A, Khalid NA, Zafar S, Majid A et al. (2024) Phage therapy as a revolutionary treatment for multidrug-resistant Pseudomonas aeruginosa infections: a narrative review. Microbe 2:100030","journal-title":"Microbe"},{"key":"15_CR19","doi-asserted-by":"crossref","unstructured":"Zhiyuan Y, Tiffany L, Selenne B, Andrew S et al (2022) Modeling multiphage-bacteria kinetics to predict phage therapy potency and longevity. bioRxiv 2022, 2022.2011.2011.516137","DOI":"10.1101\/2022.11.11.516137"},{"key":"15_CR20","doi-asserted-by":"crossref","unstructured":"Lavigne R, Lecoutere E, Wagemans J, Cenens W et al (2013) A multifaceted study of Pseudomonas aeruginosa shutdown by virulent podovirus LUZ19. mBio 4:e00061-e00013","DOI":"10.1128\/mBio.00061-13"},{"key":"15_CR21","doi-asserted-by":"publisher","first-page":"dlaf257","DOI":"10.1093\/jacamr\/dlaf257","volume":"8","author":"TD Nguyen","year":"2026","unstructured":"Nguyen TD, Sanborn J, Ho BM, Luong T et al. (2026) Pharmacodynamic Individualization of phage therapy against a KPC-5-producing Pseudomonas aeruginosa. JAC-Antimicrob Resist 8:dlaf257","journal-title":"JAC-Antimicrob Resist"},{"key":"15_CR22","doi-asserted-by":"crossref","unstructured":"\u00c1cs N, Gambino M, Br\u00f8ndsted L (2020) Bacterio-phage enumeration and detection methods. Front Microbiol 11:594868","DOI":"10.3389\/fmicb.2020.594868"},{"key":"15_CR23","volume-title":"Bacteriophages: methods and protocols","author":"MRJ Clokie","year":"2017","unstructured":"Clokie, MRJ, Kropinski, AM, Lavigne, R, 2017. Bacteriophages: methods and protocols. Springer New York, New York, NY, vol 3"},{"key":"15_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0166-0934(03)00129-0","volume":"110","author":"HG Bae","year":"2003","unstructured":"Bae HG, Nitsche A, Teichmann A, Biel SS, Niedrig M (2003) Detection of yellow fever virus: a comparison of quantitative real-time PCR and plaque assay. J Virol Methods 110:185\u2013191","journal-title":"J Virol Methods"},{"key":"15_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-1-60327-164-6_7","volume":"501","author":"AM Kropinski","year":"2009","unstructured":"Kropinski AM, Mazzocco A, Waddell TE, Lingohr E, Johnson RP (2009) Enumeration of bacteriophages by double agar overlay plaque assay. Methods Mol Biol 501:69\u201376","journal-title":"Methods Mol Biol"},{"key":"15_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/978-1-60327-164-6_18","volume":"501","author":"P Hyman","year":"2009","unstructured":"Hyman P, Abedon ST (2009) Practical methods for determining phage growth parameters. Methods Mol Biol 501:175\u2013202","journal-title":"Methods Mol Biol"},{"key":"15_CR27","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1128\/AEM.72.4.3036-3041.2006","volume":"72","author":"M Duplessis","year":"2006","unstructured":"Duplessis M, Le\u0301vesque CIM, Moineau S (2006) Characterization of Streptococcus thermophilus host range phage mutants. Appl Environ Microbiol 72:3036\u20133041","journal-title":"Appl Environ Microbiol"},{"key":"15_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00792-006-0014-5","volume":"11","author":"M Borriss","year":"2007","unstructured":"Borriss M, Lombardot T, Gl\u00f6ckner FO, Becher D et al. (2007) Genome and proteome characterization of the psychrophilic Flavobacterium bacteriophage 11b. Extremophiles 11:95\u2013104","journal-title":"Extremophiles"},{"key":"15_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/pmic.200600280","volume":"7","author":"L Eyer","year":"2007","unstructured":"Eyer L, Pant\u016f\u010dek R, Zdr\u00e1hal Z, Kone\u010dn\u00e1 H et al. (2007) Structural protein analysis of the polyvalent staphylococcal bacteriophage 812. Proteomics (Weinheim) 7:64\u201372","journal-title":"Proteomics (Weinheim)"},{"key":"15_CR30","first-page":"1","volume":"6","author":"V Serafim","year":"2017","unstructured":"Serafim V, Ring C, Pantoja Munoz L, Shah H, Shah A (2017) Rapid identification of E. coli bacteriophages using mass spectrometry. J Proteomics Enzymol 6:1\u20135.","journal-title":"J Proteomics Enzymol"},{"key":"15_CR31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/978-1-60327-565-1_14","volume":"502","author":"R Lavigne","year":"2009","unstructured":"Lavigne R, Ceyssens PJ, Robben J (2009) Phage proteomics: applications of mass spectrometry. Methods Mol Biol 502:239\u2013251","journal-title":"Methods Mol Biol"},{"key":"15_CR32","doi-asserted-by":"crossref","unstructured":"Forti F, Roach DR, Cafora M, Pasini ME et al (2018) Design of a broad-range bacteriophage cocktail that reduces Pseudomonas aeruginosa biofilms and treats acute infections in two animal models. Antimicrob Agents Chemother 62:e02573-17","DOI":"10.1128\/AAC.02573-17"},{"key":"15_CR33","doi-asserted-by":"publisher","first-page":"113354","DOI":"10.1016\/j.ab.2019.113354","volume":"582","author":"T Wang","year":"2019","unstructured":"Wang T, Nguyen A, Zhang L, Turko IV (2019) Mass spectrometry enumeration of filamentous M13 bacteriophage. Anal Biochem 582:113354","journal-title":"Anal Biochem"},{"key":"15_CR34","doi-asserted-by":"publisher","first-page":"e00061","DOI":"10.1128\/mBio.00061-13","volume":"4","author":"R Lavigne","year":"2013","unstructured":"Lavigne R, Lecoutere E, Wagemans J, Cenens W et al. (2013) A multifaceted study of Pseudomonas aeruginosa shutdown by virulent podovirus LUZ19. mBio 4:e00061\u201300013","journal-title":"mBio"},{"key":"15_CR35","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/978-1-60327-565-1_14","volume":"502","author":"R Lavigne","year":"2009","unstructured":"Lavigne R, Ceyssens P-J, Robben J (2009) Phage proteomics: applications of mass spectrometry. Bacteriophages 502:239\u2013251","journal-title":"Bacteriophages"},{"key":"15_CR36","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1021\/acs.analchem.5b00350","volume":"87","author":"B An","year":"2015","unstructured":"An B, Zhang M, Johnson RW, Qu J (2015) Surfactant-aided precipitation\/on-pellet-digestion (SOD) procedure provides robust and rapid sample preparation for reproducible, accurate and sensitive LC\/MS quantification of therapeutic protein in plasma and tissues. Anal Chem 87:4023\u20134029","journal-title":"Anal Chem"}],"container-title":["Advances in Experimental Medicine and Biology","Advancements of Mass Spectrometry in Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-29437-1_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:51:48Z","timestamp":1792601508000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/chapter\/10.1007\/978-3-032-29437-1_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032294364","9783032294371"],"references-count":36,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-29437-1_15","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"23 January 2027","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}